Sophocles Chrissobolis1, Grant R Drummond, Frank M Faraci, Christopher G Sobey. 1. aVascular Biology & Immunopharmacology Group, Department of Pharmacology, Monash University, Clayton, Victoria, Australia bDepartments of Internal Medicine and Pharmacology, Cardiovascular Center, The University of Iowa Carver College of Medicine cIowa City Veterans Affairs Healthcare System, Iowa City, Iowa, USA.
Abstract
OBJECTIVES: An elevated plasma aldosterone level is an independent cardiovascular risk factor. Although excess aldosterone promotes cardiovascular disease, no studies have examined the effect of increased plasma aldosterone on the cerebral circulation. A major source of vascular reactive oxygen species (ROS) during cardiovascular disease is the NADPH oxidases. Because Nox2-containing NADPH oxidase (Nox2 oxidase) is highly expressed in the cerebral endothelium, we postulated that it might contribute to ROS generation and vascular dysfunction in response to aldosterone. Here, we examined the effect of aldosterone and Nox2 oxidase on ROS production and endothelial dysfunction in the cerebral circulation, and whether the effects of aldosterone are exacerbated in aged mice. METHODS AND RESULTS: In adult (average age ∼24-25 weeks) wild-type and Nox2-deficient (Nox2(/y)) mice, neither vehicle nor aldosterone (0.28 mg/kg per day for 14 days) affected blood pressure (measured using tail-cuff). By contrast, aldosterone treatment reduced dilation of the basilar artery (measured using myography) to the endothelium-dependent agonist acetylcholine in wild-type mice (P < 0.05), but had no such effect in Nox2(/y) mice (P > 0.05). Aldosterone increased basal and phorbol dibutyrate-stimulated superoxide production (measured using L-012-enhanced chemiluminesence) in cerebral arteries from wild-type but not from Nox2(/y) mice. In aged wild-type mice (average age ∼70 weeks), aldosterone treatment increased blood pressure, but had a similar effect on cerebral artery superoxide levels as in adult wild-type mice. CONCLUSION: These data indicate that Nox2 oxidase mediates aldosterone-induced increases in ROS production and endothelial dysfunction in cerebral arteries from adult mice independently of blood pressure changes. Aldosterone-induced hypertension is augmented during aging.
OBJECTIVES: An elevated plasma aldosterone level is an independent cardiovascular risk factor. Although excess aldosterone promotes cardiovascular disease, no studies have examined the effect of increased plasma aldosterone on the cerebral circulation. A major source of vascular reactive oxygen species (ROS) during cardiovascular disease is the NADPH oxidases. Because Nox2-containing NADPH oxidase (Nox2 oxidase) is highly expressed in the cerebral endothelium, we postulated that it might contribute to ROS generation and vascular dysfunction in response to aldosterone. Here, we examined the effect of aldosterone and Nox2 oxidase on ROS production and endothelial dysfunction in the cerebral circulation, and whether the effects of aldosterone are exacerbated in aged mice. METHODS AND RESULTS: In adult (average age ∼24-25 weeks) wild-type and Nox2-deficient (Nox2(/y)) mice, neither vehicle nor aldosterone (0.28 mg/kg per day for 14 days) affected blood pressure (measured using tail-cuff). By contrast, aldosterone treatment reduced dilation of the basilar artery (measured using myography) to the endothelium-dependent agonist acetylcholine in wild-type mice (P < 0.05), but had no such effect in Nox2(/y) mice (P > 0.05). Aldosterone increased basal and phorbol dibutyrate-stimulated superoxide production (measured using L-012-enhanced chemiluminesence) in cerebral arteries from wild-type but not from Nox2(/y) mice. In aged wild-type mice (average age ∼70 weeks), aldosterone treatment increased blood pressure, but had a similar effect on cerebral artery superoxide levels as in adult wild-type mice. CONCLUSION: These data indicate that Nox2 oxidase mediates aldosterone-induced increases in ROS production and endothelial dysfunction in cerebral arteries from adult mice independently of blood pressure changes. Aldosterone-induced hypertension is augmented during aging.
Authors: Alyson A Miller; T Michael De Silva; Courtney P Judkins; Henry Diep; Grant R Drummond; Christopher G Sobey Journal: Stroke Date: 2010-02-18 Impact factor: 7.914
Authors: F E Xavier; R Aras-López; I Arroyo-Villa; L del Campo; M Salaices; L V Rossoni; M Ferrer; G Balfagón Journal: Br J Pharmacol Date: 2008-05-26 Impact factor: 8.739
Authors: Amy McCurley; Paulo W Pires; Shawn B Bender; Mark Aronovitz; Michelle J Zhao; Daniel Metzger; Pierre Chambon; Michael A Hill; Anne M Dorrance; Michael E Mendelsohn; Iris Z Jaffe Journal: Nat Med Date: 2012-09 Impact factor: 53.440
Authors: Janice M Diaz-Otero; Ting-Chieh Yen; Courtney Fisher; Daniel Bota; William F Jackson; Anne M Dorrance Journal: Am J Physiol Heart Circ Physiol Date: 2018-08-17 Impact factor: 4.733
Authors: Shashi Kant; Khanh-Van Tran; Miroslava Kvandova; Amada D Caliz; Hyung-Jin Yoo; Heather Learnard; Ana C Dolan; Siobhan M Craige; Joshua D Hall; Juan M Jiménez; Cynthia St Hilaire; Eberhard Schulz; Swenja Kröller-Schön; John F Keaney Journal: Arterioscler Thromb Vasc Biol Date: 2021-11-18 Impact factor: 8.311
Authors: Karen Horsburgh; Joanna M Wardlaw; Tom van Agtmael; Stuart M Allan; Mike L J Ashford; Philip M Bath; Rosalind Brown; Jason Berwick; M Zameel Cader; Roxana O Carare; John B Davis; Jessica Duncombe; Tracy D Farr; Jill H Fowler; Jozien Goense; Alessandra Granata; Catherine N Hall; Atticus H Hainsworth; Adam Harvey; Cheryl A Hawkes; Anne Joutel; Rajesh N Kalaria; Patrick G Kehoe; Catherine B Lawrence; Andy Lockhart; Seth Love; Malcolm R Macleod; I Mhairi Macrae; Hugh S Markus; Chris McCabe; Barry W McColl; Paul J Meakin; Alyson Miller; Maiken Nedergaard; Michael O'Sullivan; Terry J Quinn; Rikesh Rajani; Lisa M Saksida; Colin Smith; Kenneth J Smith; Rhian M Touyz; Rebecca C Trueman; Tao Wang; Anna Williams; Steven C R Williams; Lorraine M Work Journal: Clin Sci (Lond) Date: 2018-04-30 Impact factor: 6.124
Authors: Daniel Rodrigues; Tiago J Costa; Josiane F Silva; José Teles de Oliveira Neto; Juliano V Alves; Aline G Fedoce; Rafael Menezes Costa; Rita C Tostes Journal: Int J Mol Sci Date: 2021-06-07 Impact factor: 5.923